Speaker illustration

Doctor Yuki Fujihara

Kofu Jonan Hospital, Kofu (Japan)

Remnant lipoprotein is a residual risk of future cardiovascular events in patients with stable coronary artery disease and on statin LDL-cholesterol levels less than 70 mg/dl

Event: ESC CONGRESS 2019

Topic: Drug therapy

Session: How good/bad are we in treating lipids

Thumbnail

Significance of sarcopenia evaluation in acute decompensated heart failure: skeletal muscle mass index versus fat-free mass index

Event: ESC CONGRESS 2016

Topic: Heart failure, other

Session: Heart failure/Left ventricular function

Thumbnail

This platform is supported by

logo Novo Nordisk